Burton Shaw
Emergency Medicine · San Antonio, TXNPI 1720052889
Payments from drug & device makers
Across 144 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$545
- Amgen$319
- AstraZeneca$153
- Merck$151
- Johnson & Johnson$121
- Genentech, Inc.$103
- plus $689 from 21 others
What the payments were for
- Food & beverage$2,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $545 |
| Amgen | 20 | $319 |
| AstraZeneca | 8 | $153 |
| Merck | 15 | $151 |
| Johnson & Johnson | 9 | $121 |
| Genentech, Inc. | 1 | $103 |
| Amarin Pharma, Inc. | 5 | $87 |
| AbbVie(2 entities) | 4 | $58 |
| Gilead | 3 | $55 |
| Lilly USA, LLC | 4 | $54 |
| Avanir Pharmaceuticals, Inc. | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Genentech USA, Inc. | 3 | $43 |
| GSK | 3 | $42 |
| Astellas Pharma US Inc | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Circassia Inc. | 2 | $24 |
| Pfizer | 2 | $23 |
| Boston Scientific | 2 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Vivus LLC | 1 | $16 |
| Novartis | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xofluza$103
How this compares
$2,081 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 50 | $425 |
| Fluticasone Propionate | 16 | $389 |
| Levothyroxine Sodium | 23 | $307 |
| Rosuvastatin Calcium | 30 | $283 |
| Losartan Potassium | 28 | $248 |
| Omeprazole | 15 | $192 |
| Metformin Hcl | 28 | $173 |
| Pravastatin Sodium | 12 | $149 |
| Glimepiride | 16 | $143 |
| Benazepril Hcl | 12 | $115 |
| Metoprolol Succinate | 12 | $109 |
| Amlodipine Besylate | 29 | $107 |
| Gabapentin | 12 | $107 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $103 |
| Tamsulosin Hcl | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in San Antonio
- Brian SpearsSan Antonio$12.9M
- Grant GarboSan Antonio$1.3M
- Juan GarzaSan Antonio$868K
- James WilliamsSan Antonio$367K
- Hugh CampbellSan Antonio$103K
- Christine ZinkSan Antonio$27K
- Robert WigginsSan Antonio$21K
- Chad CrystalPalestine$26.8M
- Sinikka GreenAustin$10.2M
- James LillyDallas$8.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.